Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ovarian Neoplasms

  Free Subscription


04.11.2019

1 Br J Cancer
1 Cancer
2 Cancer Res
1 Clin Cancer Res
1 Int J Cancer
1 J Clin Oncol
1 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Br J Cancer

  1. HAMESTER F, Legler K, Wichert B, Kelle N, et al
    Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation.
    Br J Cancer. 2019 Oct 29. pii: 10.1038/s41416-019-0607.
    PubMed     Text format     Abstract available


    Cancer

  2. ESKANDER RN
    Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31902.
    PubMed     Text format    


    Cancer Res

  3. DYER A, Schoeps B, Frost S, Jakeman P, et al
    Antagonism of Glycolysis and Reductive Carboxylation of Glutamine Potentiates Activity of Oncolytic Adenoviruses in Cancer Cells.
    Cancer Res. 2019;79:331-345.
    PubMed     Text format     Abstract available

  4. SHEN J, Zhao W, Ju Z, Wang L, et al
    PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness.
    Cancer Res. 2019;79:311-319.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  5. HANDLEY KF, Sood AK
    A solution to the dilution: The role for biomarkers in advanced ovarian cancer.
    Clin Cancer Res. 2019 Oct 31. pii: 1078-0432.CCR-19-3072.
    PubMed     Text format     Abstract available


    Int J Cancer

  6. KRATZER TB, Weinstein SJ, Albanes D, Mondul AM, et al
    Vitamin D Binding Protein and Risk of Renal Cell Carcinoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
    Int J Cancer. 2019 Oct 29. doi: 10.1002/ijc.32758.
    PubMed     Text format     Abstract available


    J Clin Oncol

  7. BOULAY RM
    The Boy I Never Knew.
    J Clin Oncol. 2019;37:254-255.
    PubMed     Text format    


    Oncol Rep

  8. DONG J, Xu M
    [Corrigendum] A 19miRNA Support Vector Machine classifier and a 6miRNA risk score system designed for ovarian cancer patients.
    Oncol Rep. 2019 Oct 23. doi: 10.3892/or.2019.7385.
    PubMed     Text format     Abstract available


    PLoS One

  9. AMIT A, Sabo E, Movsas A, Efrat-Tamam Y, et al
    Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?
    PLoS One. 2019;14:e0211329.
    PubMed     Text format     Abstract available

  10. DURAN GE, Sikic BI
    The Syk inhibitor R406 is a modulator of P-glycoprotein (ABCB1)-mediated multidrug resistance.
    PLoS One. 2019;14:e0210879.
    PubMed     Text format     Abstract available

  11. MRKVICOVA A, Chmelarova M, Peterova E, Havelek R, et al
    The effect of sodium butyrate and cisplatin on expression of EMT markers.
    PLoS One. 2019;14:e0210889.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: